HHV8 ORF50 anticorps (AA 2-100) (Biotin)
-
- Antigène Tous les produits HHV8 ORF50
- HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))
-
Épitope
- AA 2-100
- Reactivité
- Human Herpesvirus 8 (HHV-8), Virus
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HHV8 ORF50 est conjugé à/à la Biotin
- Application
- Western Blotting (WB)
- Réactivité croisée
- Virus
- Réactivité croisée (Details)
- Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from N-terminus of HHV8 ORF50 strain GK18
- Isotype
- IgG
-
-
- Indications d'application
- IHC-F 1:100-500
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))
- Autre désignation
- HHV8 ORF50 (HHV8 ORF50 Produits)
- Classe de substances
- Viral Protein
- Sujet
-
Synonyms: HHV 8, Human Herpes Virus 8, Human herpesvirus 8, HHV8 ORF50, Kaposi's sarcoma associated herpes virus, Kaposi's sarcoma associated herpesvirus, KSHV, replication and transcription activator, RTA
Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
- ID gène
- 4961526
- UniProt
- F5HCV3
-